Evidence map›Paper›PMID 39224456›Full record

ArticleToxicology reports2024

Corrigendum to "Cadmium sulfide-induced toxicity in the cortex and cerebellum:

Atefeh Varmazyari, Ali Taghizadehghalehjoughi, Cigdem Sevim, Ozlem Baris, Gizem Eser, Serkan Yildirim, Ahmet Hacimuftuoglu, Aleksandra Buha, David R Wallace, Aristidis Tsatsakis and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Toxicology reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Atefeh VarmazyariDepartment of Nanoscience and Nanoengineering, Institute of Naturel and Applied Sciences, Ataturk University, Erzurum 25240, Turkey.
Ali TaghizadehghalehjoughiDepartment of Nanoscience and Nanoengineering, Institute of Naturel and Applied Sciences, Ataturk University, Erzurum 25240, Turkey.
Cigdem SevimDepartment of Pharmacology and Toxicology, Faculty of Veterinary Science, Ataturk University, Erzurum 25240, Turkey.
Ozlem BarisDepartment of Nanoscience and Nanoengineering, Institute of Naturel and Applied Sciences, Ataturk University, Erzurum 25240, Turkey.
Gizem EserVocational School of Veterinary Laboratory Assistant Program, Igdir University, İgdir76103, Turkey.
Serkan YildirimDepartment of Pathology, Faculty of Medicine Science, Ataturk University, Erzurum 25240, Turkey.
Ahmet HacimuftuogluDepartment of Pharmacology, Faculty of Medicine Science, Atatürk University, Erzurum 25240, Turkey.
Aleksandra BuhaDepartment of Toxicology "Akademik Danilo Soldatović", Faculty of Pharmacy, University of Belgrade, Belgrade 11000, Serbia.
David R WallaceDepartment of Pharmacology, School of Biomedical Sciences, Oklahoma State University Center for Health Sciences, Tulsa, OK 74107, USA.
Aristidis TsatsakisDepartment of Toxicology & Forensic Sciences, Faculty Medicine, University of Crete, Heraklion 74100, Greece.
Michael AschnerDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10463, USA.
Yaroslav MezhuevCenter of Biomaterials, D. Mendeleev University of Chemical Technology of Russia, Moscow 125047, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1016/j.toxrep.2020.04.011.].

Identifiers

PMID39224456
PMCPMC11367470

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.